Medical Treatment With Somatostatin Analogues in Acromegaly: Position Statement

The Korean Journal of Medicine
doi 10.3904/kjm.2019.94.6.485
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Korean Association of Internal Medicine

Related search

Cost-Effectiveness of Somatostatin Analogues for the Treatment of Acromegaly in Colombia

Open Journal of Endocrine and Metabolic Diseases
2012English

Interpreting Biochemical Control Response Rates With First-Generation Somatostatin Analogues in Acromegaly

Pituitary
EndocrinologyMetabolismDiabetes
2015English

Successful Primary Medical Therapy With Somatostatin Receptor Ligand in Acromegaly With Thyroid Cancer

Journal of the ASEAN Federation of Endocrine Societies
EndocrinologyMetabolismDiabetes
2017English

Clinical and Metabolic Effects of First-Line Treatment With Somatostatin Analogues or Surgery in Acromegaly: A Retrospective and Comparative Study

Pituitary
EndocrinologyMetabolismDiabetes
2011English

Long Term Treatment of a Thyrotropin-Secreting Microadenoma With Somatostatin Analogues

Arquivos Brasileiros de Endocrinologia & Metabologia
2010English

Pegvisomant in Combination With Long-Acting Somatostatin Analogues in Acromegaly: The Role of the GH Receptor Deletion of Exon 3

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2015English

Role of Somatostatin Analogues in the Treatment of Neuroendocrine Tumors

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2015English

Postoperative Use of Somatostatin Analogs and Mortality in Patients With Acromegaly.

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2019English

American Gastroenterological Association Medical Position Statement: Parenteral Nutrition

Gastroenterology
HepatologyGastroenterology
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy